Efficacy (and safety) of vaccination against SARS-CoV-2 in cancer patients on active treatment
Since the COVID-19 pandemic, cancer patients have been recognized as a group with an increased risk of complications, if they become infected with the SARS-CoV-2 virus. However, they were not included in registrational trials for COVID-19 vaccines. In the last few months data from studies investiga...
Enregistré dans:
| Auteurs principaux: | , |
|---|---|
| Format: | article |
| Langue: | SL |
| Publié: |
Institute of Oncology Ljubljana
2021
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/88e12c42dff240bfa773b79412dac2c8 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|